-transparent.png){kind=logo}
FK 506 is a new immunosuppressive drug that, like cyclosporine A (CsA), presents nephrotoxicity. Glomerular hemodynamic studies showed that acute FK 506 infusion (N = 9, 3 mg/kg body wt, i.v. in bolus) caused a 57% reduction in glomerular filtration rate (GFR) (0.74 +/- 0.03 to 0.32 +/- 0.02 ml/min, P < 0.05) and a 40% reduction in single nephron glomerular filtration rate (SNGFR; 43.0 +/- 5.2 to 26.0 +/- 2.5 nl/min, P < 0.05) due to a 25% reduction in glomerular plasma flow rate (QA) (133.4 +/- 19.8 to 99.8 +/- 12.0 nl/min) and a 22% reduction in glomerular ultrafiltration coefficient (Kf; 0.1009 +/- 0.0203 to 0.0790 +/- 0.0130 nl/sec. mm Hg). After 10 days of FK treatment (N = 8, 0.6 mg/kg body wt, i.p.), we observed a reduction of 23% in GFR (0.97 +/- 0.02 to 0.75 +/- 0.04 ml/min, P < 0.05) and of 23% in SNGFR (37.9 +/- 3.0 to 29.1 +/- 1.9 nl/min, P < 0.05) due to a 42% reduction in Kf (0.1486 +/- 0.0101 to 0.0870 +/- 0.0110 nl/sec.mm Hg, P < 0.05) and a 38% reduction in QA (117.6 +/- 10.2 to 73.5 +/- 6.1 nl/min, P < 0.05). The latter was consequent to the increment of 72% in total arteriolar resistance (RT) (3.1 +/- 0.2 to 5.2 +/- 0.5 +/- 0.5 10(10).dyn.sec.cm-5, P < 0.05). Thus, the pattern of FK 506 effect on glomerular hemodynamics was similar in both acute and chronic treatments.(ABSTRACT TRUNCATED AT 250 WORDS)
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
December 1992,
Transplantation proceedings,
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
January 1993,
European journal of clinical pharmacology,
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
December 1991,
Transplantation proceedings,
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
November 1984,
Kidney international,
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
June 1998,
Transplantation proceedings,
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
January 1990,
Nephron,
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
June 1996,
Clinical transplantation,
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
January 1998,
Advances in experimental medicine and biology,
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
December 1991,
Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
S J Hadad, and
E R Souza, and
A T Ferreira, and
M E Oshiro, and
M A Boim, and
C V Razvickas, and
L A Moura, and
N Schor
February 1976,
Laboratory investigation; a journal of technical methods and pathology,
